Nanobiotix share price logo

Nanobiotix

NASDAQ: NBTX

Small Cap

$30.66

-1.59

(-4.95%)

as on

Nanobiotix Stock Performance

as on November 14, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $30.32
    $31.50
    downward going graph

    1.11%

    Downside

    2.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $19.14
    $57.14
    downward going graph

    37.57%

    Downside

    86.37%

    Upside

    downward going graph

Nanobiotix share price movements today

Previous Close
$32.25
Open
$31.50
Volume
427.8K
Market Cap
$1.6B
Day's Low - High
$30.32 - $31.50
52 Week Low - High
$19.14 - $57.14

Nanobiotix Historical Returns

1 Month Return
+ 44.06 %
3 Month Return
-19.98 %
1 Year Return
+ 47.38 %
3 Year Return
+ 435.89 %
5 Year Return
+ 213.45 %

Nanobiotix Stock Fundamentals & Key Indicators

Check Nanobiotix market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.6B

EPS (TTM)

-1.1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-26.4

Industry PE ratio

-7.74

PEG Ratio

0.21

EBITDA

-32.9M

Revenue (TTM)

8.6M

Profit Margin

100.00%

Return On Equity TTM

89.71%

Nanobiotix vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nanobiotix with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Nanobiotix image
Nanobiotix
Buy$1.6B213.45%-26.40100.00%0.00%
Moderna image
Moderna
Neutral$100.6B0.07%-35.1828.00%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$47.5BNA68.7388.39%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$137.6B187.58%34.7885.57%0.00%
Regeneron image
Regeneron
Buy$99.2B51.37%20.2985.77%0.39%

Stock Returns calculator for Nanobiotix Stock including INR - Dollar returns

The Nanobiotix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Nanobiotix investment value today

Current value as on today

₹1,56,630

Returns

₹56,630

(+56.63%)

Returns from Nanobiotix Stock

₹47,404 (+47.4%)

Dollar Impact

₹9,226 (+9.23%)

Analyst Recommendation on Nanobiotix Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Nanobiotix. Average target price of $53.68

Nanobiotix Share Price Target

Get share price movements and forecasts by analysts on Nanobiotix.

What analysts predicted

42.88%UPSIDE

Target Price

$53.68

Current Price

$30.66

Analyzed by

1 Analysts

Target

$53.68

Nanobiotix target price $53.68, a slight upside of 42.88% compared to current price of $30.66. According to 1 analysts rating.

Indian Investors' Interest in Nanobiotix Stock

Search interest for Nanobiotix Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Nanobiotix Quarterly Profit & Loss

All numbers in Millions USD

Dec 2021
Jun 2022
Mar 2023
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Total Revenue
1
1
3
3
32
9
-16
26
3
5
Gross Profit
1
1
3
3
32
9
-16
26
3
5
Operating Income
-22
-25
-20
-25
-1
-23
-44
0
-11
-17
EBITDA
-22
-24
-20
-24
1
-22
-43
1
-13
-19
Interest Expense
-
-
3
3
3
-
-
3
6
14
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-16
-26
-30
-28
-11
-21
-46
-5
-18
-34
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-16
-26
-30
-28
-11
-21
-46
-5
-18
-34
Net Profit Margin
-14.31%
-12.26%
56.25%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Nanobiotix Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3
3
2
2
2
4
36
-7
29
Gross Profit
3
3
2
2
2
4
36
-7
29
Operating Income
-25
-30
-46
-36
-52
-46
-26
-68
-10
EBITDA
-24
-29
-45
-34
-45
-44
-22
-66
-12
Interest Expense
0
0
4
0
0
5
7
8
10
Depreciation
0
0
1
1
1
1
1
1
1
Income Before Tax
-26
-30
-50
-33
-46
-57
-39
-68
-23
Income Tax Expense
-
-
0
0
0
0
0
0
0
Net Income
-26
-30
-50
-33
-47
-57
-39
-68
-23
Net Profit Margin
-37.16%
100.00%
100.00%
100.00%
100.00%
79.38%
100.00%
100.00%
100.00%

Nanobiotix Quarterly Cash Flow

All numbers in Millions USD

Dec 2021
Jun 2022
Mar 2023
Jun 2023
Dec 2023
Jun 2024
Dec 2024
Jun 2025
Dec 2025
Jun 2026
Net Income
-16
-26
-30
-28
-11
-21
-46
-5
-18
-34
Operating Cash Flow
-14
-17
-19
-17
4
-5
-13
-17
-16
-22
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-3
-3
-2
-2
48
-2
-2
-2
40
81
Change in Cash
-18
-20
-21
-19
53
-8
-16
-20
23
56

Nanobiotix Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-30
-50
-33
-47
-57
-39
-68
-23
Operating Cash Flow
-20
-25
-41
-27
-29
-37
-12
-19
-33
Investing Cash Flow
-1
0
-1
0
0
0
0
0
0
Financing Cash Flow
48
14
41
111
-5
-5
46
-5
37
Change in Cash
26
-11
-1
84
-35
-42
33
-25
3

Global Institutional Holdings in Nanobiotix

Check out the Institutions with significant holdings in Nanobiotix.

Funds
Holdings
Fidelity Concord Street Trust
0.01%
ActivePassive
0.01%
Steward Funds Inc
0.00%

Nanobiotix News & Key Events

  • img

    Today's Timeline - 24 September

    Fri, 01:45 AM

    -

    Nanobiotix reports H1 2026 loss of €34.3M; revenue drops to €5.6M, but cash position strengthens to €110.9M.

Insights on Nanobiotix

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NBTX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, NBTX stock has moved up by 44.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.00M → 5.55M (in $), with an average increase of 45.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 801.8% return, outperforming this stock by 754.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -5.38M → -34.74M (in $), with an average decrease of 166.1% per quarter

About Nanobiotix

Nanobiotix S.A. is a clinical-stage biotechnology firm focused on developing innovative therapeutic solutions for cancer. The company's leading experimental drug, NBTXR3, is a sterile aqueous suspension comprising crystalline hafnium oxide nanoparticles. This treatment is currently undergoing development for its potential application in a broad spectrum of cancers, including soft tissue sarcoma, various head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has established a strategic collaboration with LianBio for the development and commercialization of NBTXR3 within key Asian markets, specifically Greater China, South Korea, Singapore, and Thailand. Founded in 2003, the company's main operations are situated in Paris, France.
OrganisationNanobiotix
Headquarters60 rue de Wattignies, Paris, IF, 75012, FR
IndustryBiotechnology
CEOLaurent Levy

Key Management of Nanobiotix

Name

Title

Dr. Laurent Levy Ph.D.

Co-Founder, President of the Executive Board & CEO

Dr. Louis Kayitalire M.D.

Chief Medical Officer & Member of Executive Board

Mr. Arnd Christ MBA

CFO & Member of Executive Board

Ms. Margaret Galluzzi

VP & Global Head of Clinical Operations

Dr. Leonard A. Farber M.D.

Chief Clinical and Medical Affairs Officer & Chairman of the Scientific Advisory Board

Ms. Anne-Juliette Hermant M.A.

Chief People Officer & Member of Executive Board

Mr. Earl J. Bergey Ph.d.

Co-Founder

Mr. Brandon Owens

VP of Strategic Marketing & Corporate Communication

Ms. Anne-Sophie Lariviere

Chief Product Innovation & Delivery Officer

FAQs

What is Nanobiotix share price today?

Nanobiotix share price today is $30.66 as on at the close of the market. Nanobiotix share today touched a day high of $31.50 and a low of $30.32.

What is the 52 week high and 52 week low for Nanobiotix share?

Nanobiotix share touched a 52 week high of $57.14 on and a 52 week low of $19.14 on . Nanobiotix stock price today i.e. is closed at $30.66,which is 46.34% down from its 52 week high and 60.19% up from its 52 week low.

What is Nanobiotix's market capitalisation today?

Nanobiotix market capitalisation is $0.00T as on .

How to invest in Nanobiotix Stock (NBTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Nanobiotix on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Nanobiotix Stock (NBTX) from India?

Indian investors can start investing in Nanobiotix (NBTX) shares with as little as ₹94.23999786376953 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Nanobiotix stock (as per the Rupee-Dollar exchange rate as on ). Based on Nanobiotix share’s latest price of $30.66 as on November 14, 2026 at 8:45 am IST, you will get 0.3262 shares of Nanobiotix. Learn more about fractional shares .

What are the returns that Nanobiotix has given to Indian investors in the last 5 years?

Nanobiotix stock has given 213.45% share price returns and 25.93% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?